NDC11 72606006301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 72606-0063-01 | 72606-0063 |
| 72606-0063-1 | 72606-0063 |
| 72606-063-01 | 72606-063 |
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 72606-063 | 72606-063-01 | D | Discontinued by firm | 2026-08-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Yuflyma | ADALIMUMAB-AATY | CELLTRION USA, Inc. | 526d626f-8c9f-496c-b838-00a73bb36383 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 72606-063-01 72606-063 72606006301 |